BLAIR WILLIAM & CO/IL - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 147 filers reported holding VIKING THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
BLAIR WILLIAM & CO/IL ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,002,333
-47.1%
90,545
-22.5%
0.00%
-42.9%
Q2 2023$1,894,609
+5.4%
116,879
+8.3%
0.01%0.0%
Q1 2023$1,797,284
+476.7%
107,945
+225.6%
0.01%
+600.0%
Q4 2022$311,676
+0.5%
33,157
-70.9%
0.00%0.0%
Q3 2022$310,000
-32.5%
113,788
-28.4%
0.00%
-50.0%
Q2 2022$459,000
-4.2%
158,918
-0.5%
0.00%0.0%
Q1 2022$479,000
-32.1%
159,717
+4.2%
0.00%0.0%
Q4 2021$705,000
-22.7%
153,263
+5.6%
0.00%
-33.3%
Q3 2021$912,000
-2.9%
145,181
-7.4%
0.00%0.0%
Q2 2021$939,000
-3.4%
156,736
+2.0%
0.00%
-25.0%
Q1 2021$972,000
+17.5%
153,736
+4.7%
0.00%
+33.3%
Q4 2020$827,000
+29.8%
146,826
+34.2%
0.00%0.0%
Q3 2020$637,000
+20.9%
109,401
+49.7%
0.00%0.0%
Q2 2020$527,000
+51.0%
73,066
-2.0%
0.00%
+50.0%
Q1 2020$349,000
-51.5%
74,566
-17.0%
0.00%
-50.0%
Q4 2019$720,000
-30.4%
89,821
-40.2%
0.00%
-33.3%
Q3 2019$1,034,000
-21.4%
150,308
-5.1%
0.01%
-25.0%
Q2 2019$1,315,000
-19.0%
158,458
-3.0%
0.01%
-20.0%
Q1 2019$1,623,000
+31.1%
163,283
+0.9%
0.01%
+11.1%
Q4 2018$1,238,000
+1189.6%
161,830
+2842.4%
0.01%
+800.0%
Q3 2018$96,000
+104.3%
5,500
+10.0%
0.00%
Q2 2018$47,0005,0000.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 148,000$1,638,3602.12%
Sio Capital Management, LLC 595,002$6,586,6722.04%
5AM Venture Management, LLC 585,000$6,475,9501.86%
Artia Global Partners LP 383,580$4,246,2311.76%
Integral Health Asset Management, LLC 800,000$8,856,0001.23%
Boxer Capital, LLC 2,000,000$22,140,0001.18%
DAFNA Capital Management LLC 319,655$3,538,5811.10%
Affinity Asset Advisors, LLC 332,600$3,681,8821.04%
MPM BioImpact LLC 325,000$3,597,7500.96%
Affinity Asset Advisors, LLC 300,000$3,321,0000.93%
View complete list of VIKING THERAPEUTICS INC shareholders